Cargando…
Hemodialysis in MNGIE transiently reduces serum and urine levels of thymidine and deoxyuridine, but not CSF levels and neurological function
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare, autosomal-recessive mitochondrial disorder caused by TYMP mutations presenting with a multisystemic, often lethal syndrome of progressive leukoencephalopathy, ophthalmoparesis, demyelinating neuropathy, cachexia and gastrointes...
Autores principales: | Röeben, Benjamin, Marquetand, Justus, Bender, Benjamin, Billing, Heiko, Haack, Tobias B., Sanchez-Albisua, Iciar, Schöls, Ludger, Blom, Henk J., Synofzik, Matthis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540565/ https://www.ncbi.nlm.nih.gov/pubmed/28764801 http://dx.doi.org/10.1186/s13023-017-0687-0 |
Ejemplares similares
-
Expression and Retention of Thymidine Phosphorylase in Cultured Reticulocytes as a Novel Treatment for MNGIE
por: Meinders, Marjolein, et al.
Publicado: (2020) -
Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal
por: Yadak, Rana, et al.
Publicado: (2019) -
Validation of an Immunoassay for Anti-thymidine Phosphorylase Antibodies in Patients with MNGIE Treated with Enzyme Replacement Therapy
por: Levene, Michelle, et al.
Publicado: (2018) -
Short-read genome sequencing allows ‘en route’ diagnosis of patients with atypical Friedreich ataxia
por: Fleszar, Zofia, et al.
Publicado: (2023) -
Seroprevalence of autoimmune antibodies in degenerative ataxias: a broad, disease-controlled screening in 456 subjects
por: Roeben, Benjamin, et al.
Publicado: (2023)